Mobidiag
In spring 2021, the molecular diagnostics company Mobidiag was acquired by Hologic, an American health technology company, at a historically high valuation – higher, for example, than that of the game company Rovio. The return on investment for those who invested through Springvest was almost ten-fold.
Exit type
Acquisition, 4/2021
Purchase price
€668 million
Investment multiples at exit
The investment multiple for the 11/2015 round was approx. 14.63x, for the 3/2017 round approx. 10.64x and for the 4/2018 approx. 5.85x
Investment's IRR
IRR was 61% for the 11/2015 round, 78% for the 3/2017 round and 77% for the 4/2018 round
Returns for Springvest
€12.62 million (before taxes)
11/2015, 3/2017, 4/2018
Springvest’s funding rounds
Total funding arranged by Springvest
€9.5 million
